Askenasy Nadir, Farkas Daniel L
Frankel Laboratory for Bone Marrow Transplantation, Center for Stem Cell Research, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Stem Cells. 2002;20(6):501-13. doi: 10.1634/stemcells.20-6-501.
This work describes an optical technique for characterization of the early stages of hematopoietic stem cell (HSC) engraftment under physiological conditions and in real time. Bone marrow cells (BMCs) labeled with PKH membrane linkers were injected into conditioned recipients (B10-->B10.BR mice) preoperated for placement of optical windows over femoral epiphyses. Labeled cells were tracked in vivo by fluorescence microscopy. Cellular adhesion to the BM stroma was tested with laser tweezers, and viability was assayed by the propidium iodide (PI) exclusion test, as determined from energy-transfer measurements of the pair PKH67-PI in freshly excised femurs in situ. At optimal concentrations for in vivo tracking, 1-4 micro M PKH dyes neither impaired the viability of BMCs nor the capacity of allogeneic HSCs to reconstitute hematopoiesis in myeloablated recipients. The optical window allowed in vivo visualization of 23%-26% of the PKH-labeled BMCs in the femur. The homing efficiencies at 16 hours posttransplantation were quantified as 1.77% +/- 0.15% and 0.21% +/- 0.02% for syngeneic and allogeneic BMCs, respectively. In femurs excised 16 hours after transplantation, 70% +/- 9% of the cells were adherent to the BM stroma, and two-thirds of the cells were PI negative (viable). In vivo tracking and in situ assessment of labeled HSCs in recipient BM provide important quantitative and qualitative insights into the early stages of engraftment. Correlation of early events and the efficiency of durable engraftment serve as the basis for a systematic approach toward optimization of the conditions for transplantation.
这项工作描述了一种光学技术,用于在生理条件下实时表征造血干细胞(HSC)植入的早期阶段。将用PKH膜连接剂标记的骨髓细胞(BMC)注射到预先手术在股骨骨骺上方放置光学窗口的条件受体(B10→B10.BR小鼠)中。通过荧光显微镜在体内追踪标记的细胞。用激光镊子测试细胞与骨髓基质的粘附性,并通过碘化丙啶(PI)排除试验测定活力,该试验是根据原位新鲜切除的股骨中PKH67-PI对的能量转移测量确定的。在体内追踪的最佳浓度下,1-4μM的PKH染料既不损害BMC的活力,也不损害异基因HSC在清髓受体中重建造血的能力。光学窗口允许在体内可视化股骨中23%-26%的PKH标记的BMC。移植后16小时的归巢效率分别定量为同基因和异基因BMC的1.77%±0.15%和0.21%±0.02%。在移植后16小时切除的股骨中,70%±9%的细胞粘附于骨髓基质,三分之二的细胞为PI阴性(存活)。对受体骨髓中标记的HSC进行体内追踪和原位评估,为植入的早期阶段提供了重要的定量和定性见解。早期事件与持久植入效率的相关性是优化移植条件的系统方法的基础。